JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Leveraging our human iPSC technology to revolutionize scientific research and cell therapy.
Evaluating AAV Transduction of iCell Cardiomyocytes2
Check out our new Lab Note on Evaluating AAV Transduction of iCell Cardiomyocytes2!
CIRM iPSC Repository
For a limited time, CIRM is offering a discount on research-grade human induced pluripotent stem cell (iPSC) lines
iCell® DopaNeurons TMEM175
New PD cellular model with PD risk-associated mutations, TMEM175 393M/T and 65Q/P along with isogenic controls.
Get early access now!
AD/PD 2025
Join us in Vienna, Austria on April 1st for the AD/PD International Conference on Alzheimer’s and Parkinson’s Diseases!
MARCH MADNESS WEBINARS
Join us for one of our upcoming March webinars on Neural Cells!
Human iPSC-derived cells and media for disease and preclinical research.
Licensable GMP lines for clinical & commercial manufacturing.
Contract development and cGMP manufacture of clinical-grade human cells.
Disease Modelling
Drug Discovery
Toxicology / Safety Pharm
Stem Cell Banking
See the unveiling of our new GMP production facility in Madison, WI